Back
FuelCell Energy 10K Form
Sell
37
FCEL
FuelCell Energy
Last Price:
$10.38
Seasonality Move:
14.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-10 | 10Q | FCEL/FuelCell Energy Quarterly |
2024-03-07 | 10Q | FCEL/FuelCell Energy Quarterly |
2023-09-11 | 10Q | FCEL/FuelCell Energy Quarterly |
2023-06-08 | 10Q | FCEL/FuelCell Energy Quarterly |
2023-03-09 | 10Q | FCEL/FuelCell Energy Quarterly |
2022-09-08 | 10Q | FCEL/FuelCell Energy Quarterly |
Receive FCEL News And Ratings
See the #1 stock for the next 7 days that we like better than FCEL
FCEL Financial Statistics
Sales & Book Value
Annual Sales: | $112.1M |
---|---|
Cash Flow: | $-80.3M |
Price / Cash Flow: | 0 |
Annual Sales: | $32.24 |
Price / Book: | 0.35 |
Profitability
EPS (TTM): | -7.91000 |
---|---|
Net Income (TTM): | $-126M |
Gross Margin: | $-35.9M |
Return on Equity: | -17.09% |
Return on Assets: | -13.44% |
FuelCell Energy Earnings Forecast
Key FuelCell Energy Financial Ratios
-
The Gross Profit Margin over the past 33 years for FCEL is -32.03%.
-
The Selling, General & Administrative Expenses for FCEL have been equal to 57.61% of Gross Profit Margin.
-
The Research & Development expenses have been 49.41% of Revenue.
-
The Interest Expense is -7.69% of Operating Income.
-
The Net Earning history of FCEL is -112.38% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 18 years.
FuelCell Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | FCEL |
CUSIP: | 35952H |
Website: | fuelcellenergy.com |
Debt
Debt-to-Equity Ratio: | 0.2 |
---|---|
Current Ratio: | 6.01 |
Quick Ratio: | 4.14 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
FCEL Technical Analysis vs Fundamental Analysis
Sell
37
FuelCell Energy (FCEL)
is a Sell
Is FuelCell Energy a Buy or a Sell?
-
FuelCell Energy stock is rated a SellThe current FuelCell Energy [FCEL] share price is $11.18. The Score for FCEL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.